PROVIDER PROFILE · NPI 1891947925
Tayyeba AliM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
119
Unique beneficiaries
—
Total services
205
Distinct HCPCS
4
Medicare payment
$22K
Peer benchmark
Total Medicare services vs. 2,144 Ophthalmology providers in CA — bottom quintile (cohort median 1,859).
PRESCRIBING · PART D · 2024
Total Rx claims
327
Beneficiaries
—
Total drug cost
$15K
Distinct drugs
11
Brand share
26.0%
Top prescribed drugs
Dorzolamide Hcl/Timolol Maleat64 claims
Latanoprost54 claims
Prednisolone Acetate43 claims
Timolol Maleate42 claims
Brimonidine Tartrate31 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Tayyeba Ali's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Janet Davis Ophthalmology · Miami, FL | 21 | 54 |
| Laboratory Corporation Of America Clinical Laboratory · Tampa, FL | 11 | 15 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE